acetylcysteine has been researched along with Brain Diseases, Metabolic, Familial in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdenur, JE; Boyer, M; Di Meo, I; Eftekharian, S; Sowa, M; Steenari, MR; Tiranti, V | 1 |
| Dedeoğlu, Ö; Göçmen, R; Kesici, S; Kılıç, M; Yüksel, D | 1 |
| Burlina, AB; Dweikat, I; Hildebrandt, T; Lamperti, C; Savoiardo, M; Tiranti, V; Viscomi, C; Zeviani, M | 1 |
3 other study(ies) available for acetylcysteine and Brain Diseases, Metabolic, Familial
| Article | Year |
|---|---|
Response to medical and a novel dietary treatment in newborn screen identified patients with ethylmalonic encephalopathy.
Topics: Acetylcysteine; Amino Acids; Biomarkers; Brain Diseases, Metabolic, Inborn; Cysteine; Diet; Female; Humans; Infant; Infant, Newborn; Lactic Acid; Male; Malonates; Methionine; Metronidazole; Mitochondrial Proteins; Mutation; Neonatal Screening; Nucleocytoplasmic Transport Proteins; Purpura; Sulfur | 2018 |
Successful treatment of a patient with ethylmalonic encephalopathy by intravenous N-acetylcysteine.
Topics: Acetylcysteine; Brain Diseases, Metabolic, Inborn; Coma; Female; Humans; Infant; Infusions, Intravenous; Magnetic Resonance Imaging; Malonates; Mitochondrial Proteins; Nucleocytoplasmic Transport Proteins; Purpura | 2017 |
Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy.
Topics: Acetylcysteine; Administration, Oral; Animals; Anti-Infective Agents; Brain Diseases, Metabolic, Inborn; Child, Preschool; Dioxygenases; Drug Combinations; Drug Evaluation, Preclinical; Female; Humans; Infant; Male; Malonates; Metronidazole; Mice; Mice, Knockout; Mitochondrial Proteins; Treatment Outcome | 2010 |